As biotechnology responds to the needs of the world community -- and the inherent
controversies that arise -- there is a clear unmet need for the public and policy
makers to understand how politics, regulatory decisions, investor attitudes, bioethics
and global competition will determine whether bioscience fulfills its social promise.
BioCentury and W*USA fill this need.
BioCentury This Week puts these challenges into focus. Leveraging 20 years
of unrivaled analysis of the global biotech scene through its highly recognized
weekly journals, daily newspaper and databases, BioCentury Publications develops
programs for BioCentury This Week driven by the key issues in public policy, finance
and corporate strategy that will determine whether new scientific innovations ultimately
address unmet needs in healthcare, improve nutrition and provide solutions to energy
and environmental challenges.
BioCentury This Week continues BioCentury's thoughtful, accurate and objective approach
to spotlight the views of key scientific opinion leaders, corporate decision makers,
lawmakers and policy architects, venture capitalists and other investment professionals,
and the patient and consumer groups who stand to benefit most from biotechnology.